Ishida Seiichi, Jinno Hideto, Tanaka-Kagawa Toshiko, Ando Masanori, Ohno Yasuo, Ozawa Shogo, Sawada Jun ichi
Project Team for Pharmacogenetics, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, 158-8501, Tokyo, Japan.
Biochem Biophys Res Commun. 2002 Aug 9;296(1):172-7. doi: 10.1016/s0006-291x(02)00856-2.
DNA microarrays and real time PCR were used to analyze the mechanism of gene induction by CYP1A1 inducers, beta-naphthoflavone, and omeprazole, in the human hepatocellular carcinoma HepG2 cells. Reproducible and significant inductions were observed in a limited number of genes including CYP1A1 and CYP1A2. Genes induced by omeprazole included several protein tyrosine kinase targets. This result confirmed that omeprazole could modulate gene expressions through protein tyrosine kinase-mediated pathway. Induction ratios were considerably different from CYP1A1 and CYP1A2 (>10-fold) to other induced genes (<5-fold). alpha-Naphthoflavone, which is known as an antagonist to 2,3,7,8-tetrachlorodibenzo-p-dioxin, inhibited the inductions of heme oxygenase 1, glutamate-cysteine ligase (modifier unit), and thioredoxin reductase by beta-naphthoflavone but not those of CYP1A1 and CYP1A2. It unexpectedly enhanced the beta-naphthoflavone-mediated CYP1A1 and CYP1A2 induction. These results suggest that the CYP1A1 and CYP1A2 genes, which share their 5(') enhancer regions, are regulated differently from the other genes.
采用DNA微阵列和实时定量PCR技术分析细胞色素P450 1A1(CYP1A1)诱导剂β-萘黄酮和奥美拉唑在人肝癌HepG2细胞中诱导基因的机制。在包括CYP1A1和CYP1A2在内的少数基因中观察到可重复且显著的诱导作用。奥美拉唑诱导的基因包括几个蛋白酪氨酸激酶靶点。这一结果证实奥美拉唑可通过蛋白酪氨酸激酶介导的途径调节基因表达。诱导率从CYP1A1和CYP1A2(>10倍)到其他诱导基因(<5倍)有很大差异。作为2,3,7,8-四氯二苯并对二恶英拮抗剂的α-萘黄酮可抑制β-萘黄酮对血红素加氧酶1、谷氨酸-半胱氨酸连接酶(修饰亚基)和硫氧还蛋白还原酶的诱导作用,但不影响CYP1A1和CYP1A2的诱导。出乎意料的是,它增强了β-萘黄酮介导的CYP1A1和CYP1A2诱导。这些结果表明,共享其5′增强子区域的CYP1A1和CYP1A2基因与其他基因的调控方式不同。